BIIB021

DB12359InvestigationalSmall molecule

BIIB021 has been investigated for the treatment of Tumors and Lymphoma.

Chemical structure of BIIB021
Formula / weight
C14H15ClN6O · 318.762 g/mol (avg)
Code names
BIIB-021 · CNF2024

Resolves to

Compound
UNII851B9FQ7Q0CAS848695-25-0ChEMBLCHEMBL467399ChEBI90687PubChem16736529
Structure
InChIKeyQULDDKSCVCJTPV-UHFFFAOYSA-NSMILESCOC1=C(C)C=NC(CN2C=NC3=C(Cl)N=C(N)N=C23)=C1C
Targets
P07900HSP90AA1

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with BIIB021, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In